The objectives of these recommendations (Laboratory Animals (1994) 28, 1-12) are very commendable and the care and attention to detail incorporated within the report reflect the diligence of the committee of experts who prepared it.
The Preamble points out that animals are always vulnerable to infection and in the case of laboratory species held in protected environments some of those infections, although they may be inapparent by any clinical standard, can influence the outcome of experimental procedures. A health monitoring programme which determines their presence is therefore important as it adds to the reliability and reproducibility of research data. The report proposes a scheme for monitoring breeding colonies with the intention of harmonizing procedures in countries which are members of FELASA.It represents a superb initiative by FELASAbecause, if the programme was instituted, it could not only significantly improve the reliability of research data but should also diminish the need for unnecessary repetition of studies as researchers should be able to accept data with confidence and avoid the need to check or challenge their validity.
The quality of studies which has already been achieved in the pharmaceutical and other industries by the introduction of Good Laboratory Practice (GLP)would be significantly enhanced by using a microbiologically defined animal or those which have a good health monitoring history. The report appears to acknowledge this in as much as it recommends the use of Standard Operating Procedures and a Quality Assurance Programme, both essential components of GLP. In this context it is interesting to note that as an independent initiative the laboratories involved in monitoring in the UK have recently started a Quality Assurance Programme which satisfies the suggestions in the FELASAdocument. Some laboratories in Europe have shown an interest in the programme. The report further recommends a standard reporting procedure which, if adopted, lalthough perhaps not in the form currently recommended) would also increase confidence by animal users and regulatory authorities.
But, how reasonable is it to expect the Scheme to be adopted and is there a mechanism by which it could be administered? Indeed how necessary is it for many animal users?
Some users may argue that it is not necessary. They achieve results which appear satisfactory in animals with no microbiological monitoring history. What they may not know is whether their animals meet the highest standards or although appearing clinically normal may carry organisms which influence their data and which in other studies would be found unacceptable.
Ideally the health status of the foundation stock in the breeding unit should be known. The continuing health of the progeny when moved to different environments cannot be assured but data from the breeding colony should improve confidence for the user.
The FELASArecommendations attempt to provide exactly that. They are intended for breeding colonies held in a breeding unit which is a self-contained microbiological entity. The concept of the 'self-contained microbiological entity' is an interesting one. It includes physical containment, the provision of high quality diet, water, bedding and clean utensils and all of this managed with sensible protection between man and animals. The scope of the entity could be anything from a very large commercial production unit to a small isolator.
Unfortunately, the costs of monitoring programmes are the same irrespective of the size of the breeding colony. The sampling regime is capable of detecting at least one infected animal where the assumed prevalence of a given infection is 30% and applies to any group of animals greater than 100 or so.
The largest breeders can dissipate the costs to reasonable proportions very much more easily than small or specialized breeders. Probably for this reason the application of the FELASA proposals will not be universally accepted.
However, as a long term goal, the recommendations should be encouraged. The organisms included in the proposals which have been agreed, no doubt after endless debate, are reasonable although many more could probably have been included. The assay systems also represent the best of current practice. The frequency of monitoring varies between different species. For some (mouse, rat, hamster and guineapigs) it is every 3 months, while for the rabbit it is every 6 months.
Recently the Laboratory Animal Breeders Association ILABA)revised the monitoring schedules of their Accreditation Scheme lLABAASManual 1993). They agreed to standardize the frequency of monitoring in all species, which includes the dog, ferret and cat in addition to those in the FELASA recommendations as they recognized that all breeding colonies are equally liable to change in their health status. A 3-month interval was thought to be the minimum period acceptable between sampling. The number of animals sampled on each occasion was also standardized because it was considered essential to be able to detect organisms with a prevalence as high as 30%. Unlike the FELASArecommendations laboratory Animals (1994) 28, [279] [280] LABAASbelieves it is necessary to continue monitoring for an organism even when it is known from previous results that the organism is present in the colony. If the organism is simply declared as 'positive' which is the FELASAproposal, the interpretation may be that all animals in the colony are infected. This is unlikely to be the case. By reporting the historical as well as the current data an interpretation of the significance of a particular organism can be made. The list of organisms is not identical to those of the FELASAdocument and was derived to include organisms thought to be of particular relevance in the UK.
These changes to the LABAASAccrediation Scheme undoubtedly increased the costs of monitoring, particularly for those members who breed species other than the rat and mouse. Some breeders may find it difficult to absorb these costs. If their customers do not require the reassurance of having microbiological profiles of the animals they purchase they may resent the additional costs. Yet surely it should be the user who should be striving to reduce the number of animals in their experiments. They would be encouraged to do so and this could be achieved if the biological variation which occurs due to intermittent infection could be diminished.
There is overwhelming evidence that infections in laboratory animals can often influence the outcome of experiments. Therefore, the initiative by breeders to provide animals which have been bred in microbiologically controlled conditions, where the presence of organisms likely to influence experiments is known, is surely the route to follow.
Derek Forbes (Sec. Gen.
LABAAS) c/o Division of Biomedical Services University of Leicester Leicester LEl 7RH, UK
The Report's authors reply:
We arc interested to note Dr Forbes' comments on the recent Report of the FELASAWorking Group on Animal Health and are very pleased that he has identified many positive points in the document. During the time that the recommendations were being formulated they stimulated a great deal of interest and rekindled an awareness of the importance of laboratory animal health monitoring.
Dr Forbes made some points in his letter which we feel should be addressed.
It should be emphasized that these recommendations are an important first step on the route to harmonizing health monitoring in Europe. Indeed, the Preamble states that it is the intention of FELASAto keep these recommendations under periodical review and to publish amendments as necessary. It was never Letters to the Editor the intention of the Working Group to establish, nor even suggest, mechanisms for administration or control.
However, the current revised monitoring schedules of the Laboratory Animal Breeders Association Accreditation Scheme ILABAAS) already reflect the spirit of the recommendations which state that 'Actual practice may differ from these recommendations in various ways, depending on local circumstances .... '
Not only are LABAASthe control body for the schedule as undertaken by commercial breeders, but they have varied the schedules in line with prevalence of infections in the UK.
Additionally, the FELASArecommendations have been used as the foundation upon which the LABAASschedules were based.
Thus, an existing group in the UK has already acknowledged and recognized the spirit of the recommendations.
It is certainly implicit in the recommendations that they are aimed at all breeding colonies, regardless of size. Background knowledge of health status is important in any breeding colony. In addition to the possible effects on various research projects of, particularly, subclinical infections, it would be necessary to know the health background of breeding animals when they are being moved from one environment to another.
Subclinical infections in many facilities often result in clinical disease in newly arrived, socalled 'clean', animals. This is very frustrating for the user, facility manager and animal supplier. If the background of the indigenous breeding population was known, measures could be taken to avoid such cross-contamination to the incoming 'naIve' animals.
Although the resultant costs will undoubtedly increase, the animals, even with increased health monitoring, will still represent the smallest proportion of the costs of an experiment. It is difficult to accept compromises on health monitoring because of cost considerations alone, when the possible financial and other implications of experiments invalidated by infection would be of much greater consequence.
That many university and other noncommercial facilities have already established health monitoring programmes, however, reflects the importance that is now being placed on this type of information.
The recommendations will undoubtedly continue to be a source of much debate. However, the benefits to the validity of research data in the future, as suggested by Dr Forbes, cannot be disputed.
Adrian 
